Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Pancreas
|
June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
David Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
British Journal of Cancer
|
June 29, 2016
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
E Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, et al.
Molecular Pharmaceutics
|
May 19, 2022
Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs
Taksim Ahmed, Fuh-Ching Franky Liu, Brian Lu, et al.
Cell Metabolism
|
July 30, 2020
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action
Lance A Thielen, Junqin Chen, Gu Jing, et al.
Journal of the National Cancer Institute
|
February 2, 2015
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial
David Goldstein, Robert Hassan El-Maraghi, Pascal Hammel, et al.
Pediatric Blood & Cancer
|
July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.
Breast Cancer Research and Treatment
|
May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors
Chun Wang, Zhaomei Mu, Zhong Ye, et al.
The Journal of Clinical Investigation
|
August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Honglin Jiang, Robert J Torphy, Katja Steiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Pancreas
|
June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
David Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
British Journal of Cancer
|
June 29, 2016
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
E Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, et al.
Molecular Pharmaceutics
|
May 19, 2022
Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs
Taksim Ahmed, Fuh-Ching Franky Liu, Brian Lu, et al.
Cell Metabolism
|
July 30, 2020
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action
Lance A Thielen, Junqin Chen, Gu Jing, et al.
Journal of the National Cancer Institute
|
February 2, 2015
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial
David Goldstein, Robert Hassan El-Maraghi, Pascal Hammel, et al.
Pediatric Blood & Cancer
|
July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Peter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.
Breast Cancer Research and Treatment
|
May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors
Chun Wang, Zhaomei Mu, Zhong Ye, et al.
The Journal of Clinical Investigation
|
August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Honglin Jiang, Robert J Torphy, Katja Steiger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
Page
of 5